Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpASTU:87N 88 Return-on-Tangible-Equity is 6.32% as of Jun. 2026, which is 62% below its 10-year median of 16.51. GuruFocus rates STU:87N with a GF Score™ of 88/100 and a GF Value™ of €22.17 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Stevanato Group SpA ranks better than 63.01% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Stevanato Group SpA's annualized net income for the quarter that ended in Jun. 2026 was €92 Mil. Stevanato Group SpA's average shareholder tangible equity for the quarter that ended in Jun. 2026 was €1,453 Mil. Therefore, Stevanato Group SpA's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 6.32%.
The historical rank and industry rank for Stevanato Group SpA's Return-on-Tangible-Equity or its related term are showing as below:
STU:87N'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.68 Med: 16.51 Max: 39.57
Current: 9.68
During the past 8 years, Stevanato Group SpA's highest Return-on-Tangible-Equity was 39.57%. The lowest was 9.68%. And the median was 16.51%.
STU:87N's Return-on-Tangible-Equity is ranked better than 63.01% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.83
vs STU:87N: 9.68
Stevanato Group SpA (STU:87N) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Stevanato Group SpA Return-on-Tangible-Equity Related Terms
Stevanato Group SpA Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA Return-on-Tangible-Equity Chart
STU:87N vs MMED, TFX, MMSI: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 6.32% mean?
Stevanato Group SpA (STU:87N) has a Return-on-Tangible-Equity of 6.32% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Stevanato Group SpA and its competitors. This is 62% below median its historical median of 16.51. Over the past decade, Stevanato Group SpA's Return-on-Tangible-Equity has ranged from 9.68 to 39.57. According to the industry distribution chart, Stevanato Group SpA ranks #280 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 37%.
Is Stevanato Group SpA's Return-on-Tangible-Equity too high?
Stevanato Group SpA's current Return-on-Tangible-Equity of 6.32% is 62% below median its 10-year median of 16.51. Over the past 10 years, this metric has ranged from a low of 9.68 to a high of 39.57. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.83. Stevanato Group SpA's value of 6.32% is 30.8% above this industry median. Based on the distribution chart, Stevanato Group SpA ranks #280 out of 757 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Return-on-Tangible-Equity compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #280 out of 757 companies for Return-on-Tangible-Equity. This puts Stevanato Group SpA in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.83. Stevanato Group SpA's value of 6.32% is 30.8% above this benchmark. Historically, Stevanato Group SpA's own Return-on-Tangible-Equity has ranged from 9.68 to 39.57 over the past decade. While the company's 10-year median is 16.51 vs. the industry median of 4.83, Stevanato Group SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.83, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Return-on-Tangible-Equity of 6.32% is 30.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Return-on-Tangible-Equity is 6.32%, which is 62% below median its own 10-year median of 16.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STU:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.17, compared to a current price of €17.30 — trading 22% below its estimated fair value. The current Return-on-Tangible-Equity is 6.32%, which is 62% below median its 10-year median of 16.51 and 30.8% above the Medical Devices & Instruments industry median of 4.83. Stevanato Group SpA's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Stevanato Group SpA (STU:87N), the current Return-on-Tangible-Equity is 6.32% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (STU:87N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of €17.30 is trading 22% below its estimated GF Value™ of €22.17.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for STU:87N:
Return-on-Tangible-Equity: 6.32% (62% below median its 10-year median of 16.51)
GF Value™: €22.17 vs. price of €17.30 (22% below fair value)
Industry Position: 30.8% above the Medical Devices & Instruments median (#280 of 757)
No single metric tells the full story. See the STU:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
88GF Score
Get the complete analysis for STU:87N
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:87N has been successfully added to your 
